NEWS

News Articles

ABBOTT AND TANDEM DIABETES CARE ADVANCE DEVELOPMENT OF INTEGRATED TECHNOLOGIES FOR FUTURE AUTOMATED INSULIN DELIVERY SYSTEMS

June 29, 2020

Abbott (NYSE: ABT) and Tandem Diabetes Care (NASDAQ: TNDM) announced today that they have finalized an agreement to develop and commercialize integrated diabetes solutions that combine Abbott’s world-leading1 continuous glucose monitoring (CGM) technology with Tandem’s innovative insulin delivery systems to provide more options for people to manage their diabetes. The companies first announced their intention to work…

Read More

Act-Accelerator update: Publication of investment cases

June 26, 2020

Today, the Access to COVID-19 Tools Accelerator (ACT-Accelerator) published its consolidated investment case, alongside the costed plans of the member organizations. Launched at the end of April 2020, at an event co-hosted by the Director-General of the World Health Organization, the President of France, the President of the European Commission, and The Bill & Melinda…

Read More

CSL to pay $450M to buy uniQure’s hemophilia B gene therapy

June 25, 2020

CSL Behring has struck a deal to buy uniQure’s late-phase hemophilia B gene therapy AMT-061 for $450 million upfront. The agreement will catapult CSL to the front of the race to bring a hemophilia B gene therapy to market, pitting it against companies including Pfizer.  UniQure has turned perceptions of its hemophilia B gene therapy around in…

Read More

NEW LATE-BREAKING DATA HIGHLIGHT IMPACT OF ABBOTT’S MINIMALLY INVASIVE STRUCTURAL HEART THERAPIES

June 25, 2020

Abbott (NYSE: ABT) today announced late-breaking data on a number of its life-changing products to treat people with structural heart diseases. The data included findings on the MitraClip™ system for transcatheter mitral valve repair and data on two first-in-the-world devices approved in the EU: the TriClip™ system* for transcatheter tricuspid valve repair and the Tendyne™…

Read More

LabCorp launches coronavirus neutralizing antibody test

June 25, 2020

LabCorp (NYSE:LH) has launched a new test designed to assess the capacity of antibodies in plasma to inhibit the SARS-CoV-2 virus. It says the assay can be used in the development of a COVID-19 vaccine and in screening convalescent plasma for prophylactic and therapeutic use. Read original article here

Read More

MedTech Innovator Announces Top 50 Medtech Startups Selected for Annual Showcase and Accelerator

June 24, 2020

MedTech Innovator, the premier nonprofit accelerator in the medical technology industry, today announced the 50 companies selected to participate in the organization’s flagship four-month Showcase and Accelerator program, featuring the industry’s most transformative device, diagnostic, and digital health technologies from around the globe. These up and coming startups will receive unparalleled visibility and access to…

Read More